These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 923610)
41. [Steroid receptor levels in human breast carcinomas in relation to serum hormone levels in postmenopausal patients (author's transl)]. Reiner G; Bieglmayer C; Jakesz R; Kees A; Kolb R; Spona J Wien Klin Wochenschr; 1981 May; 93(11):339-42. PubMed ID: 6791390 [TBL] [Abstract][Full Text] [Related]
42. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment. Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915 [TBL] [Abstract][Full Text] [Related]
43. Prolactin concentrations in patients with breast cancer. Franks S; Ralphs DN; Seagroatt V; Jacobs HS Br Med J; 1974 Nov; 4(5940):320-1. PubMed ID: 4434088 [TBL] [Abstract][Full Text] [Related]
44. Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with an without breast cancer. Bird CE; Cook S; Owen S; Sterns EE; Clark AF Oncology; 1981; 38(6):365-8. PubMed ID: 6795556 [TBL] [Abstract][Full Text] [Related]
45. [Prolactin and human cancer of the breast. I. Levels of correlation]. Cueto Ladrón de Guevara J; Villalba Moreno J; García Puche JL; Pedraza V Rev Esp Oncol; 1985; 32(3):439-58. PubMed ID: 3870536 [TBL] [Abstract][Full Text] [Related]
46. The distribution of oestradiol in plasma from postmenopausal women with or without breast cancer: relationships with metabolic clearance rates of oestradiol. Reed MJ; Beranek PA; Cheng RW; Ghilchik MW; James VH Int J Cancer; 1985 Apr; 35(4):457-60. PubMed ID: 4039300 [TBL] [Abstract][Full Text] [Related]
47. Plasma prolactin levels in women at postmenopausal age with a family history of breast cancer or a prescription for antihypertensive Rauwolfia treatment. de Waard F; Kwa HG; Poortman J Oncology; 1980; 37(1):33-6. PubMed ID: 7350553 [TBL] [Abstract][Full Text] [Related]
48. Serum hormone levels in British and rural Chinese females. Wang DY; Key TJ; Pike MC; Boreham J; Chen J Breast Cancer Res Treat; 1991 May; 18 Suppl 1():S41-5. PubMed ID: 1873556 [TBL] [Abstract][Full Text] [Related]
49. Plasma prolactin levels and age in a female population: relation to breast cancer. Bulbrook RD; Wang DY; Hayward JL; Kwa HG; Cleton F Int J Cancer; 1981 Jul; 28(1):43-5. PubMed ID: 7309281 [No Abstract] [Full Text] [Related]
50. The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer. McFadyen IJ; Raab G; Forrest AP; Langlands AO; Stewart HJ; Roberts MM; Hamilton T; Golder MP; Groom GV; Griffiths K Clin Oncol; 1979 Sep; 5(3):251-6. PubMed ID: 387323 [No Abstract] [Full Text] [Related]
51. The effect in post-menopausal women of natural human and artificial oestrogens on the concentration in serum of prolactin. Andersen JR; Schroeder E; Lebech PE Acta Endocrinol (Copenh); 1980 Dec; 95(4):433-7. PubMed ID: 6779473 [TBL] [Abstract][Full Text] [Related]
52. Plasma prolactin levels in patients with breast cancer. Rose DP; Pruitt BT Cancer; 1981 Dec; 48(12):2687-91. PubMed ID: 7306924 [TBL] [Abstract][Full Text] [Related]
53. A prospective study of plasma prolactin levels and subsequent risk of breast cancer. Kwa HG; Cleton F; Wang DY; Bulbrook RD; Bulstrode JC; Hayward JL; Millis RR; Cuzick J Int J Cancer; 1981 Dec; 28(6):673-6. PubMed ID: 7333701 [TBL] [Abstract][Full Text] [Related]
54. Short- and long-term fluctuations in plasma prolactin concentration in normal subjects. Djursing H; Hagen C; Møller J; Christiansen C Acta Endocrinol (Copenh); 1981 May; 97(1):1-6. PubMed ID: 6784423 [TBL] [Abstract][Full Text] [Related]
55. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors]. Holtkamp W; von Heyden D; Rauschecker H; Nagel GA Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641 [TBL] [Abstract][Full Text] [Related]
56. Plasma prolactin levels and breast cancer: relation to parity, weight and height, and age at first birth. Kwa HG; Cleton F; Bulbrook RD; Wang DY; Hayward JL Int J Cancer; 1981 Jul; 28(1):31-4. PubMed ID: 7309279 [TBL] [Abstract][Full Text] [Related]
57. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy. Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919 [TBL] [Abstract][Full Text] [Related]
58. [Relationship between benign breast cancer and plasma levels of prolactin]. Strollo F; Perniciaro G; Di Cesare T; Morè M; Marini R; Riondino G Boll Soc Ital Biol Sper; 1981 Dec; 57(23):2338-44. PubMed ID: 7337747 [TBL] [Abstract][Full Text] [Related]
59. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women. Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393 [TBL] [Abstract][Full Text] [Related]
60. Plasma membrane enzymes in human breast carcinoma: relationship with serum hormones. Ramalingam V; Krishnamoorthy G; Govindarajulu P Neoplasma; 1993; 40(6):363-7. PubMed ID: 7904728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]